The Effect of a Dexmedetomidine-focussed Sleep Protocol* on Delirium Incidence and Healthcare Costs in Critically Ill Patients: A Prospective Randomized, Double-blind, Pilot Study

Trial Profile

The Effect of a Dexmedetomidine-focussed Sleep Protocol* on Delirium Incidence and Healthcare Costs in Critically Ill Patients: A Prospective Randomized, Double-blind, Pilot Study

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Mar 2018

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Delirium
  • Focus Therapeutic Use
  • Acronyms SKY-DEX
  • Most Recent Events

    • 02 Mar 2018 Primary endpoint (Development of delirium) has been met, according to the results published in the American Journal of Respiratory and Critical Care Medicine
    • 02 Mar 2018 Results published in the American Journal of Respiratory and Critical Care Medicine
    • 15 Mar 2017 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top